Clinical trial · Interventional
Prehab for Pancreatic Cancer Surgery
Multimodal Prehabilitation Prior to Pancreatic Cancer Surgery: A Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical study is to test whether a structured prehabilitation program can be successfully used by adults with pancreatic cancer who are receiving chemotherapy before planned surgery. Prehabilitation is a program designed to improve a person's physical fitness, nutrition, and symptom control before surgery. The study's main hypothesis is that patients with pancreatic cancer can take part in and adhere to a multimodal prehabilitation program during chemotherapy, and that doing so may improve physical function, patient experience, and early recovery after surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer, Adult | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.85 |
| Prehabilitation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Multimodal Prehabilitation | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Multimodal Prehabilitation Program
- description
- Participants in this single-arm study will receive a structured prehabilitation program during neoadjuvant chemotherapy prior to planned pancreatic cancer surgery.
- interventionNames
- Behavioral: Multimodal Prehabilitation
Primary outcomes (2)
- measure
- Feasibility of prehabilitation program delivery
- timeFrame
- From enrollment through completion of neoadjuvant therapy (approximately 3-6 months)
- description
- Feasibility will be assessed by the proportion of enrolled participants who initiate and complete the prehabilitation program during neoadjuvant chemotherapy prior to surgery.
- measure
- Adherence to prehabilitation components
- timeFrame
- From enrollment through preoperative assessment (approximately 3-6 months)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of pancreatic ductal adenocarcinoma (PDAC) * Planned neoadjuvant chemotherapy prior to planned surgical resection * Medically stable and cleared to participate in physical activity/exercise programming * Able to provide informed consent * Ability to read, write and understand English Exclusion Criteria: * Age \<18 years * Pregnant * Prisoner * Severe cognitive impairment that precludes informed consent or participation * Contraindications to physical activity, including unstable cardiac disease, severe pulmonary disease, or recent myocardial infarction
References
Publications (0)
Data not yet available